Literature DB >> 6300499

Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells.

W R Shek, B W Calnek, K A Schat, C H Chen.   

Abstract

Leukocyte suspensions derived from genetically Marek's disease (MD)-resistant N-line and MD-susceptible P-line chickens were fractionated at various times after exposure to the JM-10 clone of MD virus. At 3 and 5 days post exposure (DPE), during the productive-restrictive (cytolytic) phase, most infected spleen and thymus leukocytes were found to be low-density, nylon wool-adherent cells that possessed Fc receptors and surface Ia and IgM and were depleted by carbonyl iron treatment. This was true for leukocytes derived from N-line as well as those from P-line chickens. In contrast, most infected spleen cells derived from P-line chickens during the latent phase (i.e., after 7 DPE) were not found to have the above characteristics, with one exception: Ia antigen was demonstrated on the surface of latently infected cells. From these experiments it was concluded that the principal targets of the cytolytic JM-10 infection are B-cells, whereas the subsequent latent infection was found mostly in non-B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300499

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  24 in total

1.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Persistence of Marek's disease virus in a subpopulation of B cells that is transformed by avian leukosis virus, but not in normal bursal B cells.

Authors:  E Fynan; T M Block; J DuHadaway; W Olson; D L Ewert
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  MHC-chromosome dosage effects: evidence for increased expression of Ia glycoprotein and alteration of B cell subpopulations in neonatal aneuploid chickens.

Authors:  M E Delany; R R Dietert; S E Bloom
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene.

Authors:  J L Cantello; M S Parcells; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek's disease virus strains, RB1B and Md5.

Authors:  Shiro Murata; Tsukasa Okada; Rika Kano; Yuko Hayashi; Tomoyuki Hashiguchi; Misao Onuma; Satoru Konnai; Kazuhiko Ohashi
Journal:  Virus Genes       Date:  2011-04-19       Impact factor: 2.332

6.  Status of Marek's disease virus in established lymphoma cell lines: herpesvirus integration is common.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Herpesvirus sylvilagus infects both B and T lymphocytes in vivo.

Authors:  W J Kramp; P Medveczky; C Mulder; H C Hinze; J L Sullivan
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Enzymatically inactive U(S)3 protein kinase of Marek's disease virus (MDV) is capable of depolymerizing F-actin but results in accumulation of virions in perinuclear invaginations and reduced virus growth.

Authors:  Daniel Schumacher; Caleb McKinney; Benedikt B Kaufer; Nikolaus Osterrieder
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

9.  Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis.

Authors:  Djihad Bencherit; Sylvie Remy; Yves Le Vern; Tereza Vychodil; Luca D Bertzbach; Benedikt B Kaufer; Caroline Denesvre; Laëtitia Trapp-Fragnet
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

10.  Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus.

Authors:  Luca D Bertzbach; Maria Laparidou; Sonja Härtle; Robert J Etches; Bernd Kaspers; Benjamin Schusser; Benedikt B Kaufer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.